Europe – COVID-19 vaccine safety update for Comirnaty: March 2021

The latest safety data for this vaccine are in line with the known benefit-risk profile; the
outcomes of the related assessments are presented in this update.

Diarrhoea and vomiting after vaccination have been identified as new side effects.

The benefits of Comirnaty in preventing COVID19 continue to outweigh any risks, and there
are no recommended changes regarding the use of this vaccine…